Zymeworks ZYME Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one?
- Zymeworks (ZYME) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one of $120.41M in Q1 2026.
- How has Zymeworks's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one changed year-over-year?
- Zymeworks's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one decreased by 36.3% year-over-year, from $188.94M to $120.41M.
- What is the long-term trend for Zymeworks's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one?
- Over 2 years (2023 to 2025), Zymeworks's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one has grown at a -6.9% compound annual growth rate (CAGR), from $216.38M to $187.46M.